Proposal number,Study Sponsor(s),Title,Institution,Lead researcher,URL Path
611,GSK,Long-acting beta2-agonists for chronic obstructive pulmonary disease,"Cochrane Airways Group, at St George's University of London",Kayleigh Kew,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14381&GroupID=SUMMARIES
628,GSK,Predictive and Prognostic Value of Blood Cell Ratios in Patients with Metastatic Renal Cell Carcinoma Treated with Pazopanib,"Divisions of Medical Oncology and Hematology,  Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada","Arnoud J. Templeton, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14382&GroupID=SUMMARIES
631,GSK,Predictors of BPH Progression,Duke University,"Dr. Stephen Freedland, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14383&GroupID=SUMMARIES
637,GSK,Relationship of Activated Clotting Time and Bleeding Related Outcomes in the FUTURA OASIS-8 Trial,"New York University school of Medicine, NY, NY",Sripal Bangalore,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14384&GroupID=SUMMARIES
639,GSK,Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux in Patients with Peripheral Arterial Disease,St Luke's-Roosevelt Hospital of the Columbia University of Physicians and Surgeons,Saurav Chatterjee MD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14385&GroupID=SUMMARIES
645,GSK,"The Influence of Age, Gender, and Race on the Effects of Combination Therapy with Carvedilol plus  Lisinopril  Versus Lisinopril Monotherapy for Systemic Hypertension","New York Medical College-Metropolitan Hospital Center, Department of Medicine, New York, NY",Partha Sardar,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14322&GroupID=SUMMARIES
646,GSK,Factors influencing immune response and patient outcomes following influenza vaccination.,"Health Protection Research Group, University of Nottingham",Dr Subhadra Rajanaidu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14323&GroupID=SUMMARIES
647,GSK,Assessing and Reporting Heterogeneity of Treatment Effect in Randomized Clinical Trials,"Institute for Clinical Research and Health Policy Studies, Tufts Medical Center","David M. Kent, MD, MSc",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14375&GroupID=SUMMARIES
651,GSK,Descriptive evaluation of SAE reporting rates in vaccine clinical trials among Latin American children.,P95 Pharmacovigilance and Epidemiology Services,Thomas Verstraeten,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14376&GroupID=SUMMARIES
653,GSK,Functional Estimation of Interventional Effects,"Department of Economics, Indiana University, Bloomington, Professor
Sungkyunkwan University, Professor of Economics",Joon Park,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14324&GroupID=SUMMARIES
654,"GSK, ViiV",Development of Population Pharmacokinetic/Pharmacodynamic Models for Pazopanib within the EuroTARGET project (Workpackage 7),"Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Germany",Ulrich Jaehde,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14325&GroupID=SUMMARIES
657,GSK,Use of Heparins in patients with Cancer: Individual patient-data meta-analysis of randomized trials,McMaster University,"Holger Schunemann, MD, MSc, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14326&GroupID=SUMMARIES
668,GSK,Associations between antihypertensive drugs and patterns of blood pressure changes: a strategy to reduce the burden of anti-VEGF induced hypertension,"Flinders University, School of Medicine, Adelaide, Australia; Southern Adelaide Health Network, Adelaide, Australia",Arduino A Mangoni,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14327&GroupID=SUMMARIES
669,GSK,"A multi-center, double-blind, placebo controlled study of paroxetine and imipramine in adolescents with unipolar major depression - efficacy and adverse outcomes.",University of Adelaide,Jon Jureidini,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14377&GroupID=SUMMARIES
672,GSK,The Development of Toxicity Prediction Tools to Assist Oncologists in the Management of Adverse Events in Patients Receiving Treatment with Lapatinib,Memorial Sloan-Kettering Cancer Center,Dr. Mario Lacouture,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14328&GroupID=SUMMARIES
674,GSK,Antiepileptic drug monotherapy for epilepsy: an overview of systematic reviews andnetwork meta-analysis,University of Liverpool,Antony Marson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14297&GroupID=SUMMARIES
675,Novartis,Validation study on magnitude of tumorshrinkage as a prognostic marker,"Medical School Hannover
Hematologgy, hemostasis, oncology and stemcelltransplantation
Carl-Neuberg-Str. 1
30627 Hannover, Germany",Viktor Grünwald,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14329&GroupID=SUMMARIES
679,GSK,An Epigenetic Analysis of the ALOX5 Gene Related to the Clinical Response to Montelukast,"University of North Carolina at Chapel Hill
Division of Pulmonary and Critical Care Medicine
130 Mason Farm Rd
Chapel Hill NC  27599-7020",Wayne H Anderson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14330&GroupID=SUMMARIES
681,GSK,"A randomized, double blind, placebo-controlled trial to evaluate the effect of rosiglitazone on metabolic markers in psoriasis patients",Massachusetts General Hospital,Alexa B. Kimball,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14331&GroupID=SUMMARIES
911,GSK,Outcome Measures in Systemic Lupus Erythematosus: Constructing a Meaningful Response Index from Existing Clinical Trial Data,Cedars-Sinai Medical Center,"Lindsy Forbess, MD, MSc",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14332&GroupID=SUMMARIES
918,GSK,Outcomes after Percutaneous Coronary Intervention in Cancer patients with Acute Coronary Syndrome,"New York Medical College, New York, NY.",Partha Sardar MD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14333&GroupID=SUMMARIES
928,GSK,Lung function and airway inflammation response after ozone exposure 0.25ppm,UNC Hospitals,"Krista Todoric, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14334&GroupID=SUMMARIES
930,GSK,MASTERMIND: Stratification of glycaemic response the ADOPT and RECORD studies,"NIHR Exeter Clinical Research Facility
University of Exeter Medical School
Barrack Road
Exeter
EX2 5DW","Professor Andrew Hattersley, M.D.  FRS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14335&GroupID=SUMMARIES
945,ViiV,THE CD4/CD8 RATIO AS A PREDICTOR OF NON-AIDS EVENTS DURING ANTIRRETROVIRAL THERAPY: CONFIRMATION OF ITS PREDICTIVE VALUE AND IMPACT OF MARAVIROC IN TREATMENT-EXPERIENCED PATIENTS,University Hospital Ramón y CAjal,Santiago Moreno,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14336&GroupID=SUMMARIES
946,"GSK, Novartis, Roche",Assessing models for changes in tumour size over time and how they relate to survival times.,"Division of Mathematics, University of Dundee, Dundee, UK.",Raluca Eftimie,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14337&GroupID=SUMMARIES
951,GSK,Optimized Eltrombopag Treatment of Hepatitis C virus-related thrombocytopenia,The University of Jordan,Mohammad Saleh,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14338&GroupID=SUMMARIES
955,GSK,A study of subgroup identification and micro aggregation,"National Institute of Statistical Sciences
www.niss.org",S. Stanley Young,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14339&GroupID=SUMMARIES
956,Roche,Bone Quality Project,"University of California, San Francisco",Dennis M. Black,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14278&GroupID=SUMMARIES
976,GSK,5-alpha reductase inhibitor use and risk of lung cancer,"Department of Internal Medicine
University of Manitoba

Department of Medical Oncology and Hematology
Cancercare Manitoba",Marshall Pitz,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14340&GroupID=SUMMARIES
977,GSK,The implication of central adjudication of COPD exacerbations by experts for treatment effect estimates and sample size calculation,"University of Zurich
Institute of Social and Preventive Medicine
Hirschengraben 84
CH-8001 Zurich",Milo Puhan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14341&GroupID=SUMMARIES
980,GSK,"Association of leukotriene C4 synthase gene (rs730012, -444 A/C) polymorphism with response to leukotriene modifiers treatment in asthma patients","Institute of Epidemiology and Preventive Medicine, National Taiwan University.
Department of Family Medicine, Renai Branch, Taipei City Hospital",Yi-Fan Wu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14342&GroupID=SUMMARIES
982,ViiV,Pharmacokinetic modeling of dolutegravir in HIV patients.,"National Brain Research Centre,Manesar,Haryana,Gurgaon,India-122050",V P Subramanyam Rallabandi,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14343&GroupID=SUMMARIES
988,Roche,PhD Project: Bayesian Multivariate Network Meta-Analysis of Ordered Categorical Data,School of Health and Related Research (ScHARR) at the University of Sheffield,Fabrizio Messina,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14344&GroupID=SUMMARIES
989,GSK,Assessing at the participant level the applicability of clinical trials to a specific  patient,"Lister Hill National Center for Biomedical Communications, US National Library of Medicine, NIH",Amos Cahan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14345&GroupID=SUMMARIES
993,GSK,A Spirometric Z-Score Based Reappraisal of the TORCH Study(GSK-SCO30003): Salmeterol and Fluticasone Propionate in COPD.,Yale University School of Medicine,"Carlos A. Vaz Fragoso, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14395&GroupID=SUMMARIES
995,"Boehringer Ingelheim, GSK, Lilly, Roche, Takeda, UCB",Identifying immune modulating patterns across diseases from open clinical trial data,"Institute for Computational Health Sciences
UCSF School of Medicine
Mission Hall - 550 16th St, San Francisco, CA 94158
email:Atul.Butte@ucsf.edu
Phone: 415-514-0511",,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14275&GroupID=SUMMARIES
997,GSK,Predictors of Prostate Cancer Progression Among Men on Active Surveillance,Duke University,"Stephen Freedland, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14346&GroupID=SUMMARIES
998,GSK,Determination of minimally important difference for short form 36 and Facit Fatigue for Systemic lupus erythematosus,Rush University Medical Center,"Meenakshi Jolly, MD, MSCP",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14347&GroupID=SUMMARIES
999,"Boehringer Ingelheim, GSK",Assessing the Comparative Efficacy of Therapeutics for Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of Randomized Trials,Thomson Reuters,Kristen M Sweet,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14277&GroupID=SUMMARIES
1000,GSK,Review of fever and febrile convulsion rates in children after trivalent influenza vaccine.,"National Centre for Immunisation Research and Surveillance, The Children’s Hospital at Westmead","Dr Jean Li-Kim-Moy, MBBS, FRACP",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14348&GroupID=SUMMARIES
1002,GSK,Long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease,Kansas City University of Medicine & Biosciences,Michael Sarai,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14349&GroupID=SUMMARIES
1013,GSK,Biopsy Avoidance in Patients At Risk For Prostate Cancer and in Patients With Low Risk Prostate Cancer: Developing Tools for Personalized Medicine,"Princess Margaret Cancer Centre, University Health Network, Surgical Oncology, Urologist.","Girish Kilkarni, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14350&GroupID=SUMMARIES
1015,GSK,"Pazopanib induced liver toxicity: incidence, pathogenesis and value of liver enzymes increase as a predictor of outcome in metastatic soft tissues sarcoma patients. A retrospective multi-centric study","Department of Medical Oncology
University Campus Bio-Medico
Via A. Del Portillo 200, 00128
Rome, Italy","Bruno Vincenzi, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14351&GroupID=SUMMARIES
1016,GSK,Statistical methods for estimating the duration of protection of malaria vaccines: secondary analysis of data from the RTSS/AS02A trial in Mozambique.,London School of Hygiene and Tropical Medicine,Paul Milligan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14352&GroupID=SUMMARIES
1020,GSK,Genomic prediction tools developed using phenotypes from disease progression models,University of Chicago,"Manish Sharma, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14353&GroupID=SUMMARIES
1022,Novartis,Prediction of maximal work load (Wmax)in a bicycle test in patients with COPD.,"Dept of Respiratory Medicine & Allergology
Lund University Hospital
22185 Lund, Sweden",Göran Eriksson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14298&GroupID=SUMMARIES
1028,ViiV,Impact of dolutegravir on CD4+/CD8+ ratio and CD4+ percentage in HIV-infected naive patients.,"Hospital San Pedro - Center for Biomedical Research of La Rioja (CIBIR), SPAIN",José Ramón Blanco,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14354&GroupID=SUMMARIES
1053,GSK,Validation of the spirometric LMS equations in the Spanish population,"Respiratory department, Universitary Hospital of Araba",Dr. Patricia Sobradillo,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14355&GroupID=SUMMARIES
1057,GSK,Health-related utility and disutility value in metastatic renal cell carcinoma patient treated with pazopanib,"Department of Urology, Seoul National University Hospital, College of Medicine Seoul National University",Chang Wook Jeong,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14396&GroupID=SUMMARIES
1058,ViiV,Ritonavir-boosted protease inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimens: a systematic review and individual patient data me,"Centre for Health & Infectious Diseases Research
Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases and Rheumatology,
Section 2100, Finsencentret
Blegdamsvej 9
DK-2100 Copenhagen Ø
Denmark",Alvaro H Borges,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14378&GroupID=SUMMARIES
1071,"Boehringer Ingelheim, GSK",Optimising the Analysis of vascular Prevention trials (OA-Prevention),University of Nottingham,Lisa Woodhouse,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14276&GroupID=SUMMARIES
1073,GSK,End-of-life trajectories in COPD,"CIRO+, centre of expertise for chronic organ failure; Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands",Dr. Daisy J.A. Janssen,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14356&GroupID=SUMMARIES
1075,Roche,Efficacy and Safety of Bevacizumab in the Elderly Cancer Patients: Pooled Analysis of Ten Randomized Clinical Trials,"Department of Biostatistics & Bioinformatics
Duke University",Xiaofei Wang,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14357&GroupID=SUMMARIES
1078,Lilly,Nocebo effects in the treatment of bipolar disorder: Results from an individual study participant level meta-analysis of the placebo arm of olanzapine clinical trials,"University Hospital Geelong, Australia",Seetal Dodd,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14358&GroupID=SUMMARIES
1079,ViiV,The effects of maraviroc versus efavirenz in combination with zidovudine/abacavir on the CD4/CD8 ratio in treatment-naïve HIV-infected individuals.,"Deparment of Infectious Diseases, University Hospital Ramón y Cajal, Madrid, Spaon.","Sergio Serrano-Villar, MD PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14392&GroupID=SUMMARIES
1084,GSK,Studies on the relationship between corticosteroids and unfavorable medical effects. A study based on the BLISS-52 and BLISS-76 clinical trials.,"Karolinska Institutet
Department of Medicine
Unit for Clinical Therapy Research, Inflammatory Diseases
(ClinTRID), D1:00, Karolinska University Hospital, Stockholm, Sweden","Ronald van Vollenhoven, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14359&GroupID=SUMMARIES
1085,Roche,Optimized peg-interferon alpha-2a Treatment of Hepatitis C and Hepatitis B,The University of Jordan,"Mohammad I Saleh, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14360&GroupID=SUMMARIES
1086,ViiV,Abacavir HLA-B*57:01 tolerance and genetic variation within the MHC.,"Institute for Immunology & Infectious Diseases, Discovery Way, Murdoch, WA 6150","Elizabeth Phillips, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14361&GroupID=SUMMARIES
1088,GSK,A study to identify risk factors that modify Rotarix efficacy and influence the time to rotavirus gastroenteritis among vaccinated and unvaccinated African infants.,University of North Carolina at Chapel Hill,Joann Gruber,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14284&GroupID=SUMMARIES
1090,GSK,Validating the test-negative case-control design for estimating rotavirus vaccine effectiveness using gold-standard randomized controlled trial data from South Africa and Malawi (Rota-037),"Fred Hutchinson Cancer Research Center;
Department of Biostatistics, University of Washington",M. Elizabeth Halloran,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14362&GroupID=SUMMARIES
1100,Boehringer Ingelheim,Systolic blood pressure level and risk of intracerebral hemorrhage.,"Julius Center for Health Sciences and Primary Care
UMC Utrecht",Jacoba P Greving,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14387&GroupID=SUMMARIES
1103,GSK,A study on the possible association between antidepressant response to SSRIs and proneness for side effects,"Department of Pharmacology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden","Elias Eriksson, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14363&GroupID=SUMMARIES
1108,GSK,Correlation between SF-36 PCS and MCS scores and SELENA SLEDAI activity score in SLE: a meta-anaysis.,"Division of Clinical Immunology and Allergy, Department of Internal Medicine Specialties, University Hospital and School of Medicine, Geneva, Switzerland",Chaigne Benjamin,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16138&GroupID=SUMMARIES
1125,Lilly,Initial severity and efficacy of antipsychotics for schizophrenia and bipolar mania: Individual participant level analyses of placebo-controlled studies.,Department of Psychiatry and Psychotherapy TU-München,Stefan Leucht,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14364&GroupID=SUMMARIES
1128,GSK,EuroTARGET GWAS on sunitinib pharmacogenetics in patients with metastatic renal cell carcinoma,Leiden University Medical Center (LUMC),Prof. H.J. Guchelaar,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14397&GroupID=SUMMARIES
1130,"GSK, UCB",Factors that determine placebo response in epilepsy trials,"Center for Biostatistics
Department of Population Health Science and Policy
Icahn School of Medicine at Mount Sinai 
One Gustave Levy Place, Box 1077 
New York, NY 10029",Emilia Bagiella,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14365&GroupID=SUMMARIES
1132,GSK,Cytokine patterns in anti-viral disease vaccines: a knowledge driven approach,"Division of Systems Medicine Chief
Department of Pediatrics
Stanford University","Atul J. Butte, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14366&GroupID=SUMMARIES
1134,GSK,Incidence rate and risk factors associated with Hepatocellular carcinoma development in patients with Chronic Hpatitis C and severe thrombocytopenia: the lesson from Enable studies,"AO FBF e Oftalmico, Milano Italy","Prof. Savino Bruno, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14367&GroupID=SUMMARIES
1136,Takeda,Can Machine Learning Algorithms using General Labs Predict Clinical Remission and Mucosal Healing for Patients on Vedolizumab?,University of Michigan,Peter Higgins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14283&GroupID=SUMMARIES
1137,GSK,"Immunotherapy trial simulators: Using mathematical, computational and statistical techniques to simulate trial design for new products in the treatment, vaccination and immunoprophylaxis of disease.",Imperial College London,"Roy Anderson, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14368&GroupID=SUMMARIES
1140,Boehringer Ingelheim,"Evaluation of the effect of incidental beta blocker use on clinical response to the EGFR TKI, afatinib",MD Anderson Cancer Center,"John Heymach, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14321&GroupID=SUMMARIES
1141,GSK,Multivariate methods for meta-analysis of vaccine studies with multiple correlated outcomes,"Nuffield Department of Primary Care Health Sciences, University of Oxford",Merryn Voysey,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14293&GroupID=SUMMARIES
1142,"Boehringer Ingelheim, GSK, UCB",A meta-analysis of Parkinson’s disease,"Division of Systems Medicine
Department of Pediatrics
Stanford University",Atul Butte,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14279&GroupID=SUMMARIES
1148,Lilly,Meta-analysis of the risk of relapse in bipolar disorder,FIDMAG Germanes Hospitalàries & King’s College London,Dr. Joaquim Radua,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14379&GroupID=SUMMARIES
1152,Boehringer Ingelheim,Advanced analytic methods to refine phenotyping and risk prediction among patients with atrial fibrillation in the RE-LY trial,"Yale School of Medicine
Center for Outcomes Research and Evaluation","Nihar Desai, MD, MPH",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14369&GroupID=SUMMARIES
1154,GSK,Developing New Outcome Measures for SLE by Deconvoluting Available Datasets,Lupus Research Institute,"Peter E. Lipsky, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14370&GroupID=SUMMARIES
1157,GSK,Quality-adjusted survival analysis for patients with metastatic renal cell carcinoma treated in a phase III trial of pazopanib versus sunitinib (COMPARZ trial),"Department of Urology, Seoul National University Hospital, College of Medicine Seoul National University",Chang Wook Jeong,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14398&GroupID=SUMMARIES
1159,ViiV,Validation of Pharmacokinetic/Viral Dynamic Modeling and Simulation using the Dolutegravir Phase IIa Dataset,University of Alabama at Birmingham,"Edward P. Acosta, Pharm.D.",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14280&GroupID=SUMMARIES
1160,Boehringer Ingelheim,Development of a clinical decision support tool to identify patients at high risk of early or late bleeding complications from anticoagulation,"Department of Epidemiology and Biostatistics
College of Public Health
University of Georgia
Athens, GA 30602","Mark H. Ebell MD, MS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14371&GroupID=SUMMARIES
1161,Roche,Novel approaches to the prediction of influenza complications,"Department of Epidemiology and Biostatistics
College of Public Health
University of Georgia
Athens, GA 30602",Mark H. Ebell,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14281&GroupID=SUMMARIES
1173,"GSK, Lilly",Initial severity and antidepressant efficacy for anxiety disorders: an individual patient data meta-analysis,"Interdisciplinary Center Psychopathology and Emotion regulation, Department of Psychiatry, University Medical Center Groningen, the Netherlands",Ymkje Anna de Vries,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14372&GroupID=SUMMARIES
1180,GSK,Evaluation of a platelet count threshold for bleeding risk in thrombocytopenic patients with chronic liver disease who undergo diagnostic and therapeutic invasive procedures.,"Department of Internal Medicine, University of Genoa, Genoa, Italy.",Edoardo G. Giannini,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14399&GroupID=SUMMARIES
1186,GSK,Using generalized pairwise comparisons to assess the benefit/risk balance of pazopanib vs sunitinib for patients with advanced or metastatic renal cell carcinoma,IDDI inc,Marc Buyse,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14400&GroupID=SUMMARIES
1206,GSK,Efficacy of Belimumab on Mucocutaneous Involvement in Patients with Systemic Lupus Erythematosus (MUCOBEL),"Interdisciplinary Center of Clinical Trials (IZKS), University Clinic of Mainz, Germany","Kuhn, Annegret",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14285&GroupID=SUMMARIES
1224,GSK,INTERACTION BETWEEN MENINGOCOCCAL SEROGROUP B VACCINE (BEXSERO™) AND ROUTINE INFANT VACCINES ON THE RISK OF OCCURRENCE AND RECURRENCE OF ADVERSE EVENTS FOLLOWING IMMUNIZATION.,"Institut National de Santé Publique du Québec(INSPQ)
and
Laval University",Gaston De Serres,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14401&GroupID=SUMMARIES
1234,Lilly,Predictors of Placebo Response in Pediatric Patients with Generalized Anxiety Disorder,University of Cincinnati,Jeffrey R. Strawn,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14282&GroupID=SUMMARIES
1236,GSK,COPERNICUS re-analysis,"Magdi Yacoub Institute - Heart Science Centre
National Heart & Lung Institute (Myocardial Function Section)
Harefield Hospital
Hill End Road
Harefield, Middlesex, UB9 6JH",John Cleland,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14286&GroupID=SUMMARIES
1250,"Boehringer Ingelheim, Lilly",The relationship of treatment effects and per capita income of study countries in duloxetine trials in the treatment of depressed patients,"Department of Psychiatry II, Ulm University",Markus Koesters,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14402&GroupID=SUMMARIES
1256,GSK,Population mechanistic heamatotoxicity modeling of Dapsone in G6PD deficiency patients,"Head of Department, Department of Clinical Pharmacology, Mahidol-Oxford Tropical Medicine research Unit (MORU)",Joel Tarning,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14403&GroupID=SUMMARIES
1257,GSK,An independent evaluation of the cardiovascular risk of rosiglitazone: meta-analysis of GSK’s publicly available clinical trial data,"Yale University School of Medicine
Yale-New Haven Hospital Center for Outcomes Research and Evaluation","Joseph S. Ross, MD, MHS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14287&GroupID=SUMMARIES
1258,Roche,Advance lung cancer inflammation index (ALI) in metastatic non-squamous lung cancer: A validation study,"University of Texas, Houston, Texas, USA",Syed Hasan Raza Jafri,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14292&GroupID=SUMMARIES
1273,GSK,Post-hoc analysis of placebo-controlled trials in children and adolescents with depression,University of Gothenburg,Elias Eriksson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14288&GroupID=SUMMARIES
1277,Roche,"Immunotherapy trial simulators: Using mathematical, computational and statistical techniques to simulate trial design for new products in the treatment, vaccination and immunoprophylaxis of disease.",Imperial College London,Roy Anderson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14404&GroupID=SUMMARIES
1280,GSK,Placebo and nocebo effects in migraine Ver 2,"University Hospitals Tuebingen
Dept. of Internal Medicine
Tuebingen, Germany",Paul Enck,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14289&GroupID=SUMMARIES
1292,Lilly,Applications of Item Response Theory to Clinical ADHD Research: Analysis of the ADHDRS-IV and Modeling Response to Treatments and Item-Level Treatment Sensitivity,"University of California, Los Angeles",Alex Sturm,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14314&GroupID=SUMMARIES
1293,Roche,INCIDENCE OF BRAIN METASTASES IN METASTATIC BREAST CANCER PATIENTS RECEIVING PALLIATIVE CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: A METAANYLSIS OF FIVE PROSPECTIVE RANDOMIZED PHASE III TRIALS,"Medical University of Vienna, Comprehensive Cancer Center Vienna",Rupert Bartsch,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14405&GroupID=SUMMARIES
1295,Boehringer Ingelheim,A Swapping Method Based on Covariate Classification for Average TreatmentEffect Estimation.,"University of Maryland, Baltimore County (UMBC), Department of Mathematics and statistics",Dr. Bimal Sinha,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14291&GroupID=SUMMARIES
1307,Takeda,The Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus in Patients with Chronic Kidney Disease,Seven Oaks General Hospital Renal Program,Dr. Navdeep Tangri,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14406&GroupID=SUMMARIES
1316,Boehringer Ingelheim,Blinding (Masking) and the Placebo Effect,University of Michigan Medical School,"James Brian Byrd, MD, MS, FAHA, FACC",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14407&GroupID=SUMMARIES
1320,GSK,Utility of a measure of Lupus Low Disease Activity State in SLE,Monash Health,Pei Xuan Ong (Emily),http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14408&GroupID=SUMMARIES
1321,GSK,Bone Quality Project,"University of California, San Francisco",Dennis M. Black,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14409&GroupID=SUMMARIES
1322,GSK,Comparative efficacy of different therapeutic approaches in the "naïve" patient  with chronic obstructive pulmonary disease (COPD): analysis of patient-level data,None,Giulio Pareto,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14410&GroupID=SUMMARIES
1323,Lilly,Detection of uninformative clinics during the trial of a new drug using statistical and machine learning techniques,KKT Technology pte. ltd.,Praveen Deorani,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14290&GroupID=SUMMARIES
1326,Lilly,"Reliability and Validity of the Parent Rating of Evening and Morning Behavior Scale, Revised",SUNY Upstate Medical University,"Steven V. Faraone, Ph.D.",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14411&GroupID=SUMMARIES
1331,Boehringer Ingelheim,Impact of baseline diabetes and obesity statuses on outcomes post-ischemic stroke,Medical University of South Carolina in Public Health Sciences,Colleen Bauza,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14412&GroupID=SUMMARIES
1335,"GSK, UCB",Investigation into the natural course of epilepsy and the implications on clinical trials,"NINDS, National Institutes of Health",Daniel Goldenholz,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14413&GroupID=SUMMARIES
1341,"Boehringer Ingelheim, GSK, Novartis",Vol-PACT: Improving Volumetric CT Metrics for Precision Analysis of Clinical Trial Results,"Dana-Farber Cancer Institute
Harvard Medical School",Geoffrey R. Oxnard,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14414&GroupID=SUMMARIES
1343,GSK,Improving the Assessment of Systemic Lupus Erythematosus Disease Activity,"University of Toronto, 
University Health Network",Zahi Touma,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14415&GroupID=SUMMARIES
1373,GSK,An exploratory analysis of headache in placebo controlled trials of paroxetine for generalized anxiety disorder,University of Kentucky,"Jonathan H. Smith, M.D.",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14416&GroupID=SUMMARIES
1374,GSK,A novel representation of vaccine efficacy trial datasets for use in computer simulation of vaccination policy,University of Pittsburgh,Michael M. Wagner,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14417&GroupID=SUMMARIES
1377,GSK,The association between patient outcomes under two treatments (ABOUT) in cross-over trials,"IDDI
30 avenue provinciale
1340 Louvain-la-Neuve
Belgium","Marc Buyse, ScD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14418&GroupID=SUMMARIES
1387,GSK,"Sex-differences in immunogenicity, reactogenicity and efficacy in response to vaccines in infants and young children","Nuffield Department of Primary Care Health Sciences, University of Oxford",Merryn Voysey,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14419&GroupID=SUMMARIES
1393,Roche,Prognostic influence of body mass index and body weight gain in colorectal cancer patients treated with adjuvant chemotherapy: data from The AVANT study,"Department of Internal Medicine, Seoul National University Hospital",Sae-Won Han,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14420&GroupID=SUMMARIES
1401,Sanofi,Use of Heparins in patients with Cancer: Individual patient-data meta-analysis of randomized trials,McMaster University,Holger Schunemann,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14421&GroupID=SUMMARIES
1403,ViiV,Mathematical modeling of the HIV transmission risk during the first 24 weeks after initiation of antiretroviral therapy in naïve HIV-infected MSM,Hospital General Universitario Gregorio Marañón,Juan Berenguer,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14422&GroupID=SUMMARIES
1421,GSK,Cost utility analysis comparing belimumab against rituximab in systemic lupus erythematosus,Wingate University,Chris Gillette,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14423&GroupID=SUMMARIES
1422,UCB,Developing new outcome measures for SLE by deconvoluting available data sets,LRI,"Peter E. Lipsky, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14424&GroupID=SUMMARIES
1428,Boehringer Ingelheim,Estimating absolute treatment effect of dabigatran 110 mg bid vs. 150 mg bid (vs. warfarin) for individual patients with atrial fibrillation.,"University Medical Center Utrecht, Utrecht, the Netherlands",Frank L.J. Visseren,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14425&GroupID=SUMMARIES
1430,GSK,Comparison of various remission criteria for SLE. A study based on the BLISS-52 and BLISS-76 clinical trials.,"Department of Medicine, Solna",Ronald van Vollenhoven,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14426&GroupID=SUMMARIES
1433,"Boehringer Ingelheim, Lilly, Roche",Identification of patient subgroups with enhanced treatment response in RCTs with time-to-event outcomes: use of counterfactual restricted survival times.,"INSERM U1153 METHODS team, Paris, France",Ludovic Trinquart,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14427&GroupID=SUMMARIES
1450,"Boehringer Ingelheim, Novartis",Understanding effectiveness of new drugs in older adults shortly after market entry.,Brigham and Women's Hospital and Harvard Medical School,Shirley V Wang,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14428&GroupID=SUMMARIES
1451,GSK,Assessment of bias from treatment discontinuation on mortality and exacerbations in the Towards a Revolution in COPD Health (TORCH) randomized trial,McGill University,Samy Suissa,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14429&GroupID=SUMMARIES
1452,GSK,A study to determine if prior rotavirus exposure modifies the effect of rotavirus vaccines given to infants in low- and middle-income African countries,University of North Carolina at Chapel Hill,Sylvia Becker-Dreps,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14430&GroupID=SUMMARIES
1455,Boehringer Ingelheim,Prediction of major bleeding in atrial fibrillation patients with a history of stroke or transient ischemic attack,"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands",Jacoba Greving,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14394&GroupID=SUMMARIES
1456,ViiV,Impact of ongoing side effects on the efficacy of initial antiretroviral therapy,"St Vincent's Hospital, Sydney",Andrew Carr,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14431&GroupID=SUMMARIES
1457,Lilly,Initial severity and efficacy of antipsychotics for schizophrenia and bipolar mania: Individual participant level analyses of placebo-controlled studies.,Department of Psychiatry and Psychotherapy TU-München,Stefan Leucht,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14393&GroupID=SUMMARIES
1461,Lilly,Regression discontinuity designs to evaluate real-world clinical effectiveness: a case study of drotrecogin alpha,Boston University,Allan J. Walkey,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14432&GroupID=SUMMARIES
1470,"Takeda, UCB",The efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease,"Gastroenterology Department, First Affiliated Hospital of Sun-YatSen University, Guangzhou, China

Director, IBD Service, Sheba Medical Center, Tel-Aviv University, Israel",Shomron Ben-Horin M.D.,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14433&GroupID=SUMMARIES
1473,Roche,Comparison of the pharmacokinetics of oral once-monthly 150mg ibandronate between ethnic Europeans and Taiwan post-menopausal osteoporotic women across two phase 1 studies,"(1) Department of Laboratory Medicine, National Taiwan University Hospital
(2) Institute of Epidemiology and Preventive Medicine, National Taiwan University",Keh-Sung Tsai,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14434&GroupID=SUMMARIES
1475,Boehringer Ingelheim,Predicting safety and efficacy of afatinib treatment of NSCLC,"Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia",Assoc/Prof Michael Sorich,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14435&GroupID=SUMMARIES
1481,GSK,Efficacy and safety of belimumab in childhood-onset lupus,"Columbia University Medical Center
630 168th St, Room PH 10-08
New York NY 10032","Dr Anca Askanase MD, MPH",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14436&GroupID=SUMMARIES
1514,Roche,Gain of quality-adjusted life year in patients with neovascular age-related macular degeneration after anti-VEGF treatment,"Department of Ophthalmology,
Seoul National University Bundang Hospital","Park, Sang Jun",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14437&GroupID=SUMMARIES
1526,GSK,"Assessment of correlations among all favourable and unfavourable effects for rosiglitazone/metformin, and for metformin alone, in Type 2 diabetes.","Department of Management
London School of Economics
Houghton Street
London WC2A 2AE",Lawrence D Phillips,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14438&GroupID=SUMMARIES
1528,GSK,A Swapping Method for Average Treatment Effect Estimation,"Statistics, the University of Maryland at Baltimore County (UMBC)",Bimal Sinha,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14439&GroupID=SUMMARIES
1540,GSK,IMPROVING METHODS. Our research focus is to optimize the translation of clinical trial results into clinical practice.,Brown University,Dr. Issa Dahabreh,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14440&GroupID=SUMMARIES
1541,Roche,Item calibration of the NEI VFQ-25 to improve future comparative research using patient-reported outcome (PRO) measures.,"Wilmer Eye Institute
Johns Hopkins School of Medicine",Judith E. Goldstein,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14441&GroupID=SUMMARIES
1542,Boehringer Ingelheim,Optimising the Analysis of vascular Prevention trials (OA-Prevention),University of Nottingham,Philip Bath,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14442&GroupID=SUMMARIES
1558,"GSK, Novartis",Development of historical control using placebo data from pediatric epilepsy studies,"UCB Celltech, UK",Anthony Daniels,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14443&GroupID=SUMMARIES
1566,Lilly,A microanalysis of symptoms and behaviors defining ADHD in adults and their response to both active medication and placebo,"University of Utah School of Medicine Department of Psychiatry
&
Psychiatric & Behavioral Solutions LLC",Frederick W. Reimherr MD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14444&GroupID=SUMMARIES
1567,"Boehringer Ingelheim, Takeda",Stratification of SGLT2 inhibitor glucose lowering therapy in Type 2 diabetes,"University of Exeter Medical Scool
(Honorary Consultant Physician (Diabetes) Royal Devon and Exeter Hospital)",Andrew Hattersley,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14299&GroupID=SUMMARIES
1569,GSK,Melancholic symptoms in bipolar depression and response to lamotrigine,"Department of Psychiatry, University of Saskatchewan (U of S), Saskatchewan, Canada",Dr. Evyn Peters,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14445&GroupID=SUMMARIES
1572,"Boehringer Ingelheim, Eisai, GSK, Lilly",Research to evaluate the relation of toxicity and the relative dose intensity in phase I trials beyond cycle 1 of Molecular Targeted Agents (MTAs),"Department of Breast and Medical Oncology
National Cancer Center Hospital, National Cancer Center, Japan","Kan Yonemori, MD., PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14446&GroupID=SUMMARIES
1575,"GSK, Lilly",Early improvement in individual symptoms and response to antidepressants in patients with major depressive disorder,"Interdisciplinary Center Psychopathology and Emotion regulation, University Center of Psychiatry, University Medical Center Groningen, the Netherlands",Ymkje Anna de Vries,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14447&GroupID=SUMMARIES
1581,GSK,MASTERMIND: Assessing the cost effectiveness of a stratified approach to type 2 diabetes therapy,University of Bath,Professor Chris Jennison,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14448&GroupID=SUMMARIES
1587,Astellas,Sex-specific efficacy of mirabegron for overactive bladder (OAB) symptoms: individual patient data meta-analyses,"dept. of general practice, University Medical Center Groningen, University of Groningen, the Netherlands","Marco H. Blanker, MD PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14300&GroupID=SUMMARIES
1593,GSK,JANUVIA/JANUMET HTA Submission(Germany),MSD Sharp & Dohme GmbH,Dr. Rainer Woker,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14449&GroupID=SUMMARIES
1595,"Boehringer Ingelheim, GSK, Lilly, Roche",A Novel Approach to Developing Comprehensive Profile of Adverse Event (AE) Data from Clinical Trials,Cytel Statistical Software and Services Pvt. Ltd,Sharayu Paranjpe,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14309&GroupID=SUMMARIES
1599,Roche,"Predictors of exposure, adverse and therapeutic effects of BRAF/MEK inhibitors in advanced melanoma.",Flinders University,Michael Sorich,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14450&GroupID=SUMMARIES
1600,Lilly,Item factor analysis of the SNAP-IV Parent Report Form: Generating item parameter estimates,"University of California, Los Angeles","Alexandra Sturm, Ph.D.",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14451&GroupID=SUMMARIES
1601,Sanofi,Identification of clinical biomarkers for adjuvant chemotherapy for gastric cancer after D2 dissection by analyses of individual patents’ data from large randomized controlled trials,"Chief of Surgery, JCHO Nihonmatsu Hospital
Research Professor, Fukushima Medical University","Akira Tsuburaya, MD PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14310&GroupID=SUMMARIES
1619,Boehringer Ingelheim,Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke: reanalysis of ECASS III trial to assess robustness of findings across statistical models,EBSCO Information Services,"Brian S. Alper, MD, MSPH, FAAFP",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14386&GroupID=SUMMARIES
1622,ViiV,A systematic literature review and Individual patient-level data enhanced network meta-analysis to determine the comparative efficacy and safety of first-line HIV antiretroviral therapies,School of Population and Public Health,Steve Kanters,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14452&GroupID=SUMMARIES
1624,Lilly,A Meta-analysis of Tardive Dyskinesia Rates in Studies Comparing Second Generation Antipsychotics (SGAs) with each other or to First-Generation Antipsychotics (FGAs).,The Zucker Hillside Hospital,Christoph U Correll,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14453&GroupID=SUMMARIES
1626,GSK,Factors associated with Prostate Cancer in Prostate Needle Biopsy,University of Illinois at Chicago,Daniel M. Moreira,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14454&GroupID=SUMMARIES
1629,GSK,"Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children",University of Oxford,Merryn Voysey,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14380&GroupID=SUMMARIES
1630,GSK,A framework for individualized prediction of the rate and severity of asthma exacerbations,"Faculty of Pharmaceutical Sciences and Faculty of Medicine, University of British Columbia",Mohsen Sadatsafavi,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14301&GroupID=SUMMARIES
1633,ViiV,"Comparative effect of dolutegravir and raltegravir on CD4+/CD8+ ratio, CD4%, and multiple T-cell marker recovery. SPRING-2 study.","Hospital San Pedro - Center for Biomedical Research of La Rioja (CIBIR), SPAIN",Jose Ramon Blanco,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14303&GroupID=SUMMARIES
1637,Novartis,1618 - Optimizing Patient Reported Outcomes by Linking Study Endpoints to Real-World Benchmarks,"University at Buffalo, SUNY",Dr. Jeffrey Lackner,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14455&GroupID=SUMMARIES
1640,GSK,Effect of Fluticasone/Salmeterol on Chronic Bronchitis Symptoms and Associated Patient Reported Outcomes: a post-hoc analysis of the TORCH trial,"Lewis Katz School of Medicine, Temple University.",Victor Kim,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14456&GroupID=SUMMARIES
1643,"Astellas, Lilly, Novartis, Roche",Development of an accurate statistical method for evaluating region-specific treatment effects in multiregional clinical trials,"The Institute of Statistical Mathematics, Research Organization of Information and Systems, Tokyo, Japan",Hisashi Noma,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14457&GroupID=SUMMARIES
1646,Lilly,Effects of tumor burden change (response) on survival in mesothelioma,Mayo Clinic,Aaron Mansfield,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14458&GroupID=SUMMARIES
1654,"GSK, Lilly",Placebo Response in Major Depressive Disorder.,"University of California, Los Angeles",Ariana Anderson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14389&GroupID=SUMMARIES
1660,Sanofi,Assessing the generalizability of all-cause mortality from the MOSAIC trial to older adults diagnosed with stage II and III colon cancer in SEER-Medicare,"University of North Carolina at Chapel Hill, Department of Epidemiology, Gillings School of Global Public Health",Jennifer L. Lund,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14459&GroupID=SUMMARIES
1668,Roche,Quantitative Evaluation of Circadian Rhythm of Serum Glucose Level in Caucasian and Chinese Type 2 Diabetic Patients (Oct/2016),"Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital",Pei Hu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14315&GroupID=SUMMARIES
1675,Lilly,Efficacy and tolerability of SNRIs in depression.,"Department of Pharmacology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden",Elias Eriksson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14460&GroupID=SUMMARIES
1684,Roche,"ANSELMA
Antiangiogenic agents in advanced non-small cell lung cancer patients who failed first-line chemotherapy: an individual patient data meta-analysis",Gustave Roussy,BENJAMIN BESSE,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14294&GroupID=SUMMARIES
1688,Novartis,Translational data from LPT109096 to assess the impact of HER2-targeted therapies on HER-family and stem cell marker expression.,"National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.",Denis Collins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14374&GroupID=SUMMARIES
1691,GSK,Longitudinal Concurrent and Predictive Biomarkers of Clinical Disease Severity in Systemic Lupus Erythematosus in BLISS-52/BLISS-76,Pfizer,Austin Huang,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14296&GroupID=SUMMARIES
1692,"Boehringer Ingelheim, GSK",Predictors  of chronic obstructive pulmonary disease progression,"Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba university, Chiba, Japan",Akihiro Hisaka,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14311&GroupID=SUMMARIES
1693,"Lilly, Novartis",Identifying Subgroups of Response to Biologics in Psoriasis using Large-scale Patient-level Data,University of Manchester,Nophar Geifman,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14511&GroupID=SUMMARIES
1695,GSK,Outcome measures and baseline predictors of response to belimumab treatment.,"Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden",Ioannis Parodis,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14312&GroupID=SUMMARIES
1702,Roche,Pooled analysis of cardiac safety of T-DM1 in HER2-positive metastatic breast cancer patients,"Institut Jules Bordet
BrEAST Data Center, Brussels Belgium",Evandro de Azambuja,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14304&GroupID=SUMMARIES
1707,Lilly,Comparative Effectiveness Analysis with Data From Randomized Clinical Trials and Observational Studies,"The University of Hong Kong
Duke University (Adjunct)",Herbert Pang,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14461&GroupID=SUMMARIES
1721,"Lilly, Roche",Improving the evaluation of new cancer therapies to expedite patient access,University of Adelaide,Professor Jonathan Karnon,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14295&GroupID=SUMMARIES
1726,"Takeda, UCB",Association Between Obesity and Response to Biologic Therapy in Inflammatory Bowel Diseases,University of California San Diego,Siddharth Singh,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14512&GroupID=SUMMARIES
1731,GSK,"Host characteristics impacting Rotarix immunogenicity and correlates of protection for rotavirus gastroenteritis, a multi-site pooled analysis of individual-level clinical trial data","Department of Epidemiology, Rollins School of Public Health, Emory University",Julia M. Baker,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14302&GroupID=SUMMARIES
1732,"Astellas, Boehringer Ingelheim, GSK, Lilly, Novartis, Roche, Sanofi, Takeda, UCB","Assessing heterogeneity in relative treatment efficacy by age, sex and comorbidity.",University of Glasgow,Dr David A McAllister,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14388&GroupID=SUMMARIES
1733,Roche,Identifying Trajectories of Disease Activity States in Juvenile Idiopathic Arthritis (JIA) Early After Treatment: Shortening Time to Decision to Change Treatment,"Rady Faculty of Health Sciences, University of Manitoba
Children's Hospital Research Institute of Manitoba, University of Manitoba",Lily Lim,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16103&GroupID=SUMMARIES
1741,"Lilly, Novartis, Roche","Predictors of exposure, therapeutic and adverse effects of drugs used in the treatment of advanced breast cancer and advanced colorectal cancer.",Flinders University,Dr Ashley Mark Hopkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14316&GroupID=SUMMARIES
1749,"GSK, Novartis, Roche",Bisphosphonates for the Treatment of Osteoporosis In Chronic Kidney Disease: an Individual Patient Level Systematic Review and Meta-Analyses,"Division of Nephrology, Department of Medicine, McMaster University, Department of Health Research Methods, Evidence and Impact, affiliated to Research St. Joseph's - Hamilton",Dr. David Collister,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19507&GroupID=SUMMARIES
1752,GSK,Sex Differences in responses to umeclidinium-vilanterol treatment in COPD patients,"Istituto superiore di sanità, Italy",Elisabetta Straface,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14462&GroupID=SUMMARIES
1758,Novartis,Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of Chronic Kidney Disease,Tufts Medical Center/Tufts Medical School,"Lesley A. Inker, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14463&GroupID=SUMMARIES
1764,"Sanofi, Takeda",Personalized Medicine Model Builder and Evaluation for Diabetes Treatments,"Queens College, CUNY and the Wharton Business School of the University of Pennsylvania",Adam Kapelner,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14317&GroupID=SUMMARIES
1779,GSK,Evaluation of the effect of inhaled corticosteroids (ICS) on blood eosinophil count (EOS) in patients with COPD,"Division of Infection, Immunity and Respiratory Medicine
University of Manchester, UK",Professor Jørgen Vestbo DMSc FRCP FERS,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14318&GroupID=SUMMARIES
1786,"Lilly, Novartis, UCB",The efficacy of biologic medications in improving depressive symptoms in patients with psoriasis and PsA – Patient-level meta-analysis of randomized clinical trials data,"University of Toronto, Women's College Hospital, Toronto, ON, Canada",Dr Lihi Eder,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19617&GroupID=SUMMARIES
1794,Roche,A study to identify the associated factor of reported adverse event severity among HER2-positive metastatic breast cancer patient from clinical trials.,"Centre for Investigational New Product, National Pharmaceutical Regulatory Agency (NPRA) Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia",OH CHEN WEI,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19787&GroupID=SUMMARIES
1808,"Roche, UCB",Long-term predictive value of patient global assessment regarding radiographic damage and physical function in patients with Rheumatoid Arthritis: individual patient data meta-analysis,"Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal.",José A. P. da Silva,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16104&GroupID=SUMMARIES
1813,Takeda,Comparative efficacy of biologics in resolving extraintestinal manifestations of inflammatory bowel disease (IBD): a systematic review and meta-analysis,Mayo Clinic,"Purna C. Kashyap, MBBS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19827&GroupID=SUMMARIES
1816,"Lilly, Roche","Individual patients data based meta-analysis of randomized trials assessing the interest of molecularly targeted treatments of advanced/recurrent stomach cancer:
A meta-analysis by the GASTRIC group","Gustave Roussy Cancer Center
Biostatistics and epidemiology dpt
INSERM CESP U1018 OncoStat
Meta-analysis platform
114 rue Ed Vaillant 94805 Villejuif cedex, France",Xavier Paoletti,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14390&GroupID=SUMMARIES
1819,GSK,INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF ANTIDEPRESSANT TRIALS FOR MAJOR DEPRESSION IN JAPAN,Hiroshima University,Shigeto Yamawaki,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14464&GroupID=SUMMARIES
1831,"GSK, Novartis, Takeda",Statistical Methods Research to Compare the Performance of New Estimators of the Treatment Effect in Alzheimer’s Disease Randomized Trials,"Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University",Michael Rosenblum,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14513&GroupID=SUMMARIES
1843,GSK,The genetics of glycaemic response to GLP-1 receptor agonists in Type 2 diabetes,University of Dundee Dundee  DD1 9SY,Ewan Pearson,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14306&GroupID=SUMMARIES
1844,GSK,Real World Effects of Medications for Chronic Obstructive Pulmonary Disease,London School of Hygiene & Tropical medicine (LSHTM),Dr Kevin Wing,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14305&GroupID=SUMMARIES
1847,Sanofi,Antiangiogenic Second line Lung cancer Meta-Analysis (ANSELMA) - A meta-analysis on antiangiogenic agents in advanced non-small cell lung cancer patients who failed first-line chemotherapy.,"University Paris-Sud and Gustave Roussy, Department of Medicine 
114 Rue Edouard Vaillant, 94805 Villejuif Cedex, France
Phone: +33 (0)1 42 11 43 22 
Fax:  +33 (0)1 42 11 52 19",Benjamin Besse,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14307&GroupID=SUMMARIES
1851,Roche,Validation of a Novel Outcome Instrument for SLE Clinical Trials Using Phase II Rontalizumab Study Data Set.,UCSD School of Medicine,Kenneth Kalunian,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19508&GroupID=SUMMARIES
1857,"GSK, Novartis",Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia: a systematic review and individual patient data network meta-analysis,"Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael’s Hospital",Andrea C. Tricco,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19509&GroupID=SUMMARIES
1880,"Boehringer Ingelheim, Eisai, Lilly, Roche, Sanofi",Improving the evaluation of new cancer therapies to expedite patient access,University of Adelaide,Professor Jonathan Karnon,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16123&GroupID=SUMMARIES
1907,GSK,Critical characterization of the impact of clinical-pathological tumoral features  on recurrence risk dynamics of NSCLS.,"European institute of Oncology , Milan",Tommaso De Pas,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14313&GroupID=SUMMARIES
1911,"Boehringer Ingelheim, Daiichi Sankyo",Lower incidence of atrial fibrillation in NOAC treated patients without prior AF,"Department of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands",Ömer Erküner,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19666&GroupID=SUMMARIES
1925,GSK,"EstablishINg the best STEp-up treatments for children with uncontrolled asthma despite Inhaled corticosteroids (EINSTEIN): A systematic review, network meta-analysis and cost effectiveness analysis",University of Liverpool,Catrin Tudur Smith,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19874&GroupID=SUMMARIES
1928,GSK,The development of a disease progression model to describe the long-term effects of anti-diabetic medications on Hemoglobin A1C,The University of Jordan,Mohammad Saleh,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14319&GroupID=SUMMARIES
1933,Novartis,"Benefit-harm assessment of Fingolimod: a novel methodology to inform patients with MS, industry, guideline developers and regulatory agencies on the balance of benefits and harms","University of Zurich
Institute of Social and Preventive Medicine
Hirschengraben 84
CH-8001 Zurich",Alessandra Spanu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14373&GroupID=SUMMARIES
1934,GSK,Using zanamivir trial data to evaluate baseline characteristics and disease progression by various subgroups to inform clinical development of novel therapies in hospitalized patients with influenza,"Genentech, Inc., A member of the Roche Group",Lesley Butler,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14308&GroupID=SUMMARIES
1955,Boehringer Ingelheim,Development and validation of a model to predict absolute vascular risk reduction due to intensive blood-pressure targets in individual patients at baseline and after three months,"University Medical Center Utrecht, Utrecht, the Netherlands",F.L.J. Visseren,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14320&GroupID=SUMMARIES
1973,Roche,The Role of Targeted Agents and Their Effects on Lymphocytes and Patient Outcomes,Investigational Drug Branch  Cancer Therapy Evaluation Program  Division of Cancer Treatment and Diagnosis  National Cancer Institute,Elad Sharon,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20107&GroupID=SUMMARIES
1996,Sanofi,Statistical Methods for Causal Inference Adjusting for Adherence,"Southern Methodist University Department of Statistics
University of Texas Southwestern Medical Center Department of Clinical Sciences",Daniel Heitjan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14585&GroupID=SUMMARIES
2029,"GSK, Lilly",Matching the Right Antidepressants with the Right Patients: Using Artificial Intelligence to Personalize the Treatment of Depression,Douglas Mental Health University Institute McGill University,Gustavo Turecki,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19916&GroupID=SUMMARIES
2033,Boehringer Ingelheim,Applying machine learning tools to personalize dabigatran treatment decisions,Stanford University,Sanjay Basu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19665&GroupID=SUMMARIES
2036,Boehringer Ingelheim,Prediction of bleeding events in patients with non-valvular atrial fibrillation - validation of the VTE-BLEED score,"Leiden University Medical Centre, Leiden, Netherlands",Menno V Huisman,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14515&GroupID=SUMMARIES
2056,Lilly,Breakthrough on Antipsychotic Maintenance Medication: An Individual Participant Data Meta-Analysis.,"The Zucker Hillside Hospital,
The Feinstein Institute of Biomedical Research
Northwell Health",Jose M Rubio M.D.,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14391&GroupID=SUMMARIES
2069,Lilly,Estimating the impact of different approaches to the analysis of time-to-event and longitudinal data on modelled cost-effectiveness.,"School of Health and Related Research (ScHARR), The University of Sheffield",Ben Kearns,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19510&GroupID=SUMMARIES
2074,Roche,Association between pertuzumab induced diarrhea and cutaneous rash and survival outcomes in patients with HER2-positive metastatic breast cancer enrolled in the CLEOPATRA trial,Institut Jules Bordet,Evandro de Azambuja,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19788&GroupID=SUMMARIES
2084,GSK,Relationship between plasma levels of  a1-Antitrypsin levels and the severity of  airflow limitation,"Pneumology Department. Hospital Universitari Vall d'Hebron. Barcelona, Spain",Marc Miravitlles,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14586&GroupID=SUMMARIES
2085,GSK,Identify Systemic Lupus Erythematosus (SLE) Patients Treated with Belimumab with Reduced Severe and Severe/Moderate Flares: A Post-hoc Trial Analysis,"Johns Hopkins University
Bloomberg School of Public Health
Department of Health Policy and Management
Center for Drug Safety and Effectiveness
Center for Population Health IT",Hongjun Kan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14516&GroupID=SUMMARIES
2087,Lilly,Effectiveness of rhGH in Children with GHD in GeNeSIS (NCT01088412) - revised,"Founder and Chief Scientific Officer, Ammonett Pharma

Retired from University of Virginia after serving on faculty for 40 years as a clinical investigator, Division Chief Endocrinology and Metabolism, Chairman of the Department of Medicine",Michael O. Thorner,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14514&GroupID=SUMMARIES
2099,Boehringer Ingelheim,Blood pressure variability in PRoFESS and development of incident stroke,"University of Utah, Department of Neurology",Adam de Havenon,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16161&GroupID=SUMMARIES
2100,GSK,Review of post-vaccination fever and antipyretic use and their relation to vaccine immunogenicity after quadrivalent influenza vaccine in children.,"National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead",Dr Jean Li-Kim-Moy,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19618&GroupID=SUMMARIES
2110,Lilly,Effects of tumor burden change (response) on survival in mesothelioma,Mayo Clinic,Aaron Mansfield,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=14517&GroupID=SUMMARIES
5453,Roche,Evaluation of Postmastectomy Radiotherapy in Women with HER-2 positive Breast Cancer,"American University of Beirut, Medical Center ",Youssef Zeidan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19511&GroupID=SUMMARIES
5459,GSK,"Placebo Effects in Asthma Randomized Clinical Trials: Their Magnitudes, Causes and Potential for Improving Care","The Ottawa Hospital Research Institute, University of Ottawa",Shawn D. Aaron,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16122&GroupID=SUMMARIES
5460,GSK,The evaluation of hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection against laboratory-confirmed influenza infections,"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong.",Prof Benjamin J Cowling,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16162&GroupID=SUMMARIES
5471,GSK,Evaluating predictors of antidepressant response or remission in children and adolescents with depression,"University of Maryland Baltimore, School of Pharmacy, Pharmaceutical Health Services Research Department","O'Mareen Spence, MPH",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19822&GroupID=SUMMARIES
5494,Sanofi,Improving Colon Cancer Therapy Decisions by Extending Trial Representation,"Department of Epidemiology, University of North Carolina at Chapel Hill",Jennifer Lund,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19512&GroupID=SUMMARIES
5495,Boehringer Ingelheim,Applying clinical trial results in clinical decision-making: Impact of a patien's baseline risk on the relative effect of an intervention strategy.,"University Medical Center Utrecht, Utrecht, the Netherlands",Frank L.J. Visseren,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19662&GroupID=SUMMARIES
5499,Roche,Incorporating biomarkers into survival models to predict patient,Rutgers University,"Dr. Luigi Brunetti, PharmD, MPH",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19754&GroupID=SUMMARIES
5501,Roche,Efficacy and Tolerability of Trastuzumab-Emtansine in Elderly Patients with Advanced Breast Cancer; A Combined Analysis ,Institut Jules Bordet,Noam Pondé,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19789&GroupID=SUMMARIES
5502,Lilly,Health Determinants of the quality of life among children with ADHD: a structural equation modelling approach,"National Research Council, Neuroscience Institute, Padova, Italy",Nadia Minicuci,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16105&GroupID=SUMMARIES
5504,Boehringer Ingelheim,Estimating Oral Anticoagulant Comparative Effectiveness in the Setting of Effect Heterogeneity: Comparing Clinical Trial Transport and Observational Epidemiologic Methods,University of North Carolina at Chapel Hill,Michael Webster-Clark,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19664&GroupID=SUMMARIES
5505,"Boehringer Ingelheim, Lilly",A Data-Driven Statistical/Machine Learning Analysis for Extracting Clinically Actionable Predictions of Antidepressant Treatment Outcomes with Individual Depressive Symptoms,"Mayo Clinic, Dept. of Psychiatry and Psychology",William V. Bobo,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19663&GroupID=SUMMARIES
5506,Lilly,Development of a limited sampling strategy for pharmacokinetic studies with pemetrexed.,Radboud University Medical Center,Rob ter Heine,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19619&GroupID=SUMMARIES
5509,Boehringer Ingelheim,Statistical methodology for the analysis of incomplete data in non-inferiority clinical trials.,"University of Connecticut, Department of Statistics, CT, USA",Yulia Sidi,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19513&GroupID=SUMMARIES
5513,"Lilly, Novartis",Association of sunlight intensity with Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and interactions with pharmacological treatment: A cross-sectional approach.,"Research Institute Brainclinics, Nijmegen, The Netherlands Utrecht University, Dept. of Experimental Psychology, Utrecht, The Netherlands",Martijn Arns,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19620&GroupID=SUMMARIES
5515,GSK,Impact of HPV16/18 vaccine on HPV genotype infection and cervical precancerous lesions: an implication for cervical cancer screening strategy,"National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences",Fanghui Zhao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16121&GroupID=SUMMARIES
5521,GSK,Impact of HPV vaccination in preventing subsequent infection and disease after excision treatment,"National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences",Fanghui Zhao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=16124&GroupID=SUMMARIES
5525,GSK,Novel approaches for the analysis of SLE clinical trials,Albert Einstein College of Medicine,Mimi Kim,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19514&GroupID=SUMMARIES
5528,Boehringer Ingelheim,Spirometric Z-Score Reappraisal of the UPLIFT Trial: A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease,Yale University School of Medicine,"Carlos A. Vaz Fragoso, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19667&GroupID=SUMMARIES
5548,"Boehringer Ingelheim, Lilly, Roche","Predictors of exposure, therapeutic and adverse effects of targeted therapeutics used in the treatment of lung cancer.",Flinders University,Ashley Hopkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19752&GroupID=SUMMARIES
5549,Boehringer Ingelheim,Model-based meta-analysis of anticoagulant therapy based on individual patient data,"Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan ",Hisaka Akihiro ,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19904&GroupID=SUMMARIES
5565,Eisai,"Predictors of exposure, therapeutic and adverse effects of lenvatinib used in the treatment of advanced thyroid cancer.",Flinders University,Ashley Hopkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19826&GroupID=SUMMARIES
5567,Lilly,PROCLAIM trial secondary analysis: Request for data to determine pre- and mid-treatment neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios and lymphocyte nadir values to analyze if they are predictive of survival outcome.,"University Hospitals Siedman Cancer Center, Case Western Reserve University, Cleveland, OH",Tithi Biswas,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19755&GroupID=SUMMARIES
5602,Roche,"Predictors of exposure, therapeutic and adverse effects of atezolizumab used in the treatment of advanced cancers.",Flinders University,Ashley Hopkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19756&GroupID=SUMMARIES
5625,Roche,Investigating the effects of rituximab on specific cell subsets and cytokine levels in systemic lupus erythematosus patients and constructing a prediction model of treatment response,Stanford University,Matthew Baker,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19823&GroupID=SUMMARIES
5642,GSK,FEV1 decline across BMI gradient in COPD patients who were part of large randomized controlled trial over at least 3 years.,"Centre for Heart Lung Innovation, St Paul's Hospital and Division of Respiratory Medicine, University of British Columbia,Vancouver, BC V6Z 1Y6, Canada ",Don D Sin,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19915&GroupID=SUMMARIES
5644,"GSK, Lilly, Sunovion",Factor analysis using the Generalisability Theory of PANSS data from clinical trials in schizophrenia and bipolar disorder,"University Hospital Geelong, Barwon Health, Geelong, Australia",Seetal Dodd,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19903&GroupID=SUMMARIES
5652,UCB,Efficacy of Crohn's Disease Treatment Stratified by Disease Phenotype,University of California - San Francisco,Vivek Rudrapatna,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19786&GroupID=SUMMARIES
5655,"Astellas, Bayer, Boehringer Ingelheim, GSK, Lilly, Roche, Sanofi, Takeda, ViiV",Prediction of recruitment in randomized clinical trials (RECRUIT-IT),"Department of Medical Oncology & Institute for Clinical Epidemiology and Biostatistics,  University Hospital Basel, Basel, Switzerland ",Kasenda Benjamin,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20252&GroupID=SUMMARIES
5658,GSK,Does Shingrix vaccination reduces the risk of stroke?,University of Antwerp & Antwerp University Hospital,Benson Ogunjimi,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19753&GroupID=SUMMARIES
5742,"Boehringer Ingelheim, GSK, Novartis",Comparison of the effects of dual and single bronchodilators in COPD patients relocated from group D to group B by the revised 2017 GOLD classification: a post-hoc pooled analysis of global RCTs,"Professor, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Head, the Department of Pulmonary and Critical Care Medicine, Asan Medical Center, Seoul, South Korea ",Yeon-Mok Oh,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19825&GroupID=SUMMARIES
5758,Roche,Predicting the real world effectiveness and safety of medical interventions ,"Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland",Orestis Efthimiou,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20042&GroupID=SUMMARIES
5769,GSK,The risk of recurrent Plasmodium vivax malaria and haematological effect of treatment with or without primaquine: a systematic review and individual patient data meta-analysis,"Menzies School of Health Research, Darwin, Australia  WorldWide Antimalarial Resistance Network (WWARN), University of Oxford, UK",Rob Commons,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20040&GroupID=SUMMARIES
5775,Roche,Early identification of immunotherapy response based on computational models,"Applied Tumor Immunity (D120) National Center for Tumor Diseases (NCT) German Cancer Research Center (DKFZ) Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany   Gastroenterology and Gastrointestinal Oncology University Hospital RWTH Aachen Pauwelsstraße 30, D-52074 Aachen, Germany ",Jakob Nikolas Kather,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20044&GroupID=SUMMARIES
5783,Sanofi,"Co Medication (aspirin, statins and metformin) analysis in patients with metastatic Castration Resistant Prostate Cancer treated with Chemotherapy.",VALL D HEBRON INSTITUTE OF ONCOLOGY VALL D'HEBRON  UNIVERSITY HOSPITAL Passeig Vall d'Hebron 119-129 08035 BARCELONA,Joan CARLES,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20732&GroupID=SUMMARIES
5791,Novartis,Trends of CRT therapy in heart failure patients with reduced ejection fraction on LCZ696 versus Enalapril,University of Miami,Abdullah Sarkar MD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20257&GroupID=SUMMARIES
5793,"Astellas, UCB","Predictors of exposure, therapeutic and adverse effects of certolizumab pegol used in the treatment of rheumatoid arthritis.","Australian Center for Pharmacometrics, School of Pharmacy and Medical Sciences, University of South Australia",Ahmad Y Abuhelwa,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19910&GroupID=SUMMARIES
5796,GSK,Symptom level analysis of recovery during antidepressant treatment,"Department of Psychology and Logopedics, Medical Faculty, University of Helsinki, Helsinki, Finland",Markus Jokela,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19981&GroupID=SUMMARIES
5805,GSK,Choosing the Right Antidepressant for Depression: Individual Patient Data Network Meta-Analysis ,"Department of Psychiatry, University of Oxford &#9; Oxford Health NHS Foundation Trust ",Professor Andrea Cipriani ,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20255&GroupID=SUMMARIES
5806,GSK,Melancholic depression and response to lamotrigine for the treatment of acute bipolar depression: a pooled analysis of five randomized controlled trials,"Department of Psychiatry, College of Medicine, University of Saskatchewan",Dr. Evyn Peters,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19876&GroupID=SUMMARIES
5807,"Lilly, Novartis, Roche","Predictors of exposure, therapeutic and adverse effects of medicines used in the treatment of breast cancer.",Flinders University,Ashley Hopkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20043&GroupID=SUMMARIES
5808,Roche,Effect of rheumatoid factor and anticitrullinated peptide antibody on the efficacy of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis,Leiden University Medical Center,Diane van der Woude,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19872&GroupID=SUMMARIES
5809,Roche,Effectiveness of anti HER2 blockade according to host immune status,Gangnam Severance Hospital Department of Surgery,Joon Jeong,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19873&GroupID=SUMMARIES
5814,UCB,Calculating the Ankylosing Spondylitis Disease Activity Score (ASDAS) in radiographic and non-radiographic axial spondyloarthritis when Patient Global Assessment (PGA) is not available,Leiden University Medical Center (LUMC),Désirée van der Heijde,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19911&GroupID=SUMMARIES
5815,GSK,Examining statistical methods to allow comprehensive evaluation and presentation of adverse event data in randomised controlled trials,Imperial College London,Rachel Phillips,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19821&GroupID=SUMMARIES
5819,GSK,The immunogenicity and efficacy of pneumococcal vaccines: a systematic review and network meta-analysis of individual participant data ,University of Oxford,Merryn Voysey,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19913&GroupID=SUMMARIES
5835,GSK,Combined effect of belimumab and hydroxychloroquine treatment : results from the phase 3 belimumab clinical trials in patients with SLE,"Center of Research of Immunopathology and Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.",Savino Sciascia,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19824&GroupID=SUMMARIES
5836,Roche,Exploring possibilities to improve the risk:benefit balance through anlaysis of the ocrelizumab phase II extension study,Blizard Institute  Barts and the London School of Medicine and Dentistry Queen Mary University of London 4 Newark Street London EC1 2AT,David Baker/Klaus Schmierer,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20354&GroupID=SUMMARIES
5847,GSK,Effectivity of Belimumab in arthritic and hematologic SLE manifestations,Dep. of Internal Medicine III Carl Gustav Carus Medical Center University of Dresden Germany,Nicolai Leuchten,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20251&GroupID=SUMMARIES
5851,Novartis,Statistical Methods for Analyzing KCCQ in Heart Failure Trials ,"Department of Mathematics & Statistics University of Maryland Baltimore County Baltimore, MD","DoHwan Park, Ph.D.",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20105&GroupID=SUMMARIES
5855,GSK,A clinical practice for detecting the phases of Herpes Zoster.,"* Athens University of Economics and Business, Department of Statistics (www.stat-athens.aueb.gr )  * Frontier Science Foundation Hellas (www.frontier-science.gr )",Dimitris Karlis,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19875&GroupID=SUMMARIES
5862,GSK,Impact of belimumab on antiphospholipid antibodies in patients with Systemic Lupus Erythematosus,"1st Department of Propaedeutic and Internal Medicine, Laiko Hospital, Medical School, National and Kapodistrian University of Athens, Greece",Katerina Chatzidionysiou,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19877&GroupID=SUMMARIES
5865,GSK,Hospitalized influenza clinical studies: benchmarking and refinement of clinical endpoints,Biomedical Advanced Research and Development Authority (BARDA) Office of the Assistant Secretary for Preparedness and Response (ASPR) Department of Health and Human Services (HHS),Kimberly Armstrong,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19901&GroupID=SUMMARIES
5880,Roche,Assessing immune system correlates to individual tumour size dynamics  ,"University of Manchester, Manchester, UK",Dr Hitesh Mistry,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19949&GroupID=SUMMARIES
5881,Novartis,Relationship between outcomes and systolic blood pressure reduction during the first 24 h in acute heart failure syndrome: an exploratory analysis of the Relax-AHF-studies ,"The University of Copenhagen, and the Department of Cardiology, Bispebjerg Hospital, 2400 Copenhagen NV, Denmark",Olav Wendelboe Nielsen,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20109&GroupID=SUMMARIES
5886,GSK,Efficacy of belimumab in patients with active systemic lupus erythematosus and concomitant antiphospholipid syndrome,"Istituto Auxologico Italiano, IRCCS, Laboratory of Immunorheumatology, Milan, Italy.",Pier Luigi Meroni,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19950&GroupID=SUMMARIES
5895,ViiV,Pharmacogenetics of Interaction between Efavirenz and Dolutegravir,"Vanderbilt University Medical Center Nashville, Tennessee","David W. Haas, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19984&GroupID=SUMMARIES
5904,"Lilly, Roche",Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer,Iowa State University,Benjamin K Schneider,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20253&GroupID=SUMMARIES
5906,UCB,Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs,University of Liverpool,Laura Bonnett,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20250&GroupID=SUMMARIES
5915,GSK,SLE clinical and laboratory profiling to indentify best response to belimumab: results from the phase III belimumab clinical trials,"Center of Research of Immunopathology and Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. MD, Consultant in Clinical Immunology",Savino Sciascia,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19902&GroupID=SUMMARIES
5936,"Takeda, UCB",The impact of biological interventions on health-related quality of life in adults with Crohn's disease,"UHC rijeka, krešimirova 42, 51000 Rijeka, Croatia",Mirjana Stanic Benic,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20258&GroupID=SUMMARIES
5937,Roche,"Predictors of exposure, therapeutic and adverse effects of tocilizumab used in the treatment of rheumatoid arthritis.",University of South Australia,Ahmad Y Abuhelwa,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19914&GroupID=SUMMARIES
5951,Lilly,Alternative Data Presentation For Treatment Outcomes in Psoriasis,"University of Alberta, Faculty of Medicine & Dentistry, Division of Dermatology, Canada",Robert Gniadeki,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19983&GroupID=SUMMARIES
5979,Lilly,"Predictors of exposure, therapeutic and adverse effects of baricitinib used in the treatment of rheumatoid arthritis.","Australian Center for Pharmacometrics, School of Pharmacy and Medical Sciences, University of South Australia",Ahmad Y Abuhelwa,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19912&GroupID=SUMMARIES
5981,Roche,Multi-state models for the analysis of survival data in radiation therapy. ,"Department of Radiotherapy, Paoli Calmettes Institute, Marseille, France.",Pierre Annede,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20041&GroupID=SUMMARIES
5988,"Lilly, Novartis, Roche",Pattern Extraction and Patient-Level Prediction of Adverse Events Using Meta-Analysis and Matrix Decomposition,Tokyo University of Science,Kentaro Matsuura,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19982&GroupID=SUMMARIES
5995,Novartis,An investigation of clinical outcome measures in PPMS to inform the design of investigator initiated clinical trials.,"University of Calgary, Calgary, Alberta, Canada",Marcus Koch MD PhD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20108&GroupID=SUMMARIES
6001,Lilly,Can I use machine learning to build a prediction model of individual patient outcome in first episode psychosis?,"Institute of Mental Health & Wellbeing, University of Glasgow  Honorary Specialty Registrar General Adult Psychiatry, NHS Greater Glasgow & Clyde",Dr Samuel Leighton,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=19948&GroupID=SUMMARIES
6009,GSK,Examining Immune Setpoints in Children and Adults Who Received Multivalent Hepatitis B Vaccines ,J. Craig Venter Institute (JCVI),Yun Zhang,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20335&GroupID=SUMMARIES
6042,"Eisai, GSK, Sanofi",An investigation into unblinded sample size re-estimation methodology in clinical trials,The University of Sheffield,Julia Edwards,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20254&GroupID=SUMMARIES
6044,"GSK, Sanofi","Is there a Difference in the Immune Response, Efficacy, and Safety of Seasonal Influenza Vaccine in Males and Females? - A Meta-Analysis.","Department of Microbiology, Infectious diseases & Immunology and CHU Sainte-Justine Research Center, Université de Montréal, Montréal, QC, Canada",Caroline Quach,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20874&GroupID=SUMMARIES
6062,Sanofi,Predictors of placebo response to local (intra-articular) therapy in osteoarthritis: an individual patient data meta-analysis ,"Institute of Bone and Joint Research, University of Sydney Department of Rheumatology, Royal North Shore Hospital. Sydney, Australia",Shirley Yu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20937&GroupID=SUMMARIES
6066,Novartis,"Evaluating the role of Clinical Study Reports, as unpublished sources of evidence for the use of sacubitril/valsartan in adults and its impact on evidence synthesis.",Department of General Practice and HRB Centre for Primary Care Research,Dr David Byrne,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20334&GroupID=SUMMARIES
6078,"Novartis, Roche",Evaluation of Radiotherapy after Complete Response to Neoadjuvant Chemotherapy in HER-2 Positive Breast Cancer Patients,"American University of Beirut, Medical Center",Youssef Zeidan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20106&GroupID=SUMMARIES
6080,Roche,Exploratory Analysis of CRANE Influenza Study to Assess Impact of MHAA4549A among Subgroups Classified by Influenza Severity,Veristat,Robin Bliss,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20248&GroupID=SUMMARIES
7080,"Roche, Sanofi",The clinical outcome based on the treatment course factors in CLASSIC trial.,"Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan ",Hisaka Akihiro,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20394&GroupID=SUMMARIES
7082,Roche,Evaluation of Radiotherapy Boost in Women with HER-2 positive Breast Cancer. ,"Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon.",Youssef Zeidan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20039&GroupID=SUMMARIES
8102,GSK,Open Label Extension Analysis - Exploring Self-Controlled Case Series Methodology,London School of Hygiene and Tropical Medicine,Ian Douglas,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20336&GroupID=SUMMARIES
9115,GSK,inhaled STerOids for the Prevention of Lung Cancer. (STOP Lung Cancer),Clínica Universidad de Navarra,Luis Seijo,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20351&GroupID=SUMMARIES
9131,GSK,Validation of the diabetes microsimulation model in the HARMONY trial,University of Florida College of Pharmacy,Hui Shao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20339&GroupID=SUMMARIES
9134,ViiV,Population pharmacokinetic analysis of interaction between dolutegravir and rifampin,Department of Medicine University of Cape Town Health Sciences Faculty,Gary Maartens,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20256&GroupID=SUMMARIES
9136,Novartis,Association Between Blood Pressure and Cardiovascular Outcomes in Liver Transplant Recipients. ,Northwestern University Feinberg School of Medicine,Lisa B VanWagner MD MSc FAST FAHA,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20733&GroupID=SUMMARIES
9140,Eisai,INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF DONEPEZIL FOR ALZHEIMER'S DISEASE,Kyoto University Graduate School of Medicine / School of Public health,Toshi A. Furukawa,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20249&GroupID=SUMMARIES
10141,GSK,Impact of rotavirus genotype and local rotavirus gastroenteritis incidence on Rotarix vaccine efficacy estimates: a multi-site pooled analysis of individual-level clinical trial data,"Department of Epidemiology, Rollins School of Public Health, Emory University",Avnika B. Amin,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20398&GroupID=SUMMARIES
10189,Roche,Evaluation of Radiotherapy in Triple Negative Breast Cancer: Analysis of the BEATRICE trial ,"American University of Beirut, Medical Center ",Youssef Zeidan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20263&GroupID=SUMMARIES
10195,GSK,Relationship Between Baseline Blood Electrolyte Levels and Risk of Asthma Exacerbation,Gossamer Bio,Greg Opitek,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20337&GroupID=SUMMARIES
10204,Novartis,Validity of Renal Transplant Outcomes in the Australian and New Zealand Dialysis and Transplant Registry: Comparison with Clinical Trials Data,"Employer: Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia  Research Affiliation: University of Sydney, Sydney, NSW, Australia",Tracey Ying,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20397&GroupID=SUMMARIES
11223,"Novartis, Roche, Sanofi",Individualizing Treatment Decisions for Adult Relapsing-Remitting Multiple Sclerosis Patients Using Statistical Learning Methods,"Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland",Prof Dr Ulrike Held,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20600&GroupID=SUMMARIES
11229,GSK,Exploration of the Hospital Recovery Scale as an endpoint to assess clinical improvement in hospitalized influenza patients ,Janssen R&D Belgium,Wilbert van Duijnhoven,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20340&GroupID=SUMMARIES
11230,Sanofi,A systematic review of prognostic biomarkers in idiopathic pulmonary fibrosis,University of Nottingham ,Prof Gisli Jenkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20598&GroupID=SUMMARIES
11236,GSK,Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) validation: post-hoc analysis of the BLISS-52 and BLISS-76 phase III trials.,"Professor of Rheumatology and Head of the CHUC Lupus Clinic, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra. Coimbra, Portugal Professor of Rheumatology at Faculty of Health Sciences, University of Beira Interior. Covilhã, Portugal",Luís Inês,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20268&GroupID=SUMMARIES
11254,GSK,"Evaluation of the pharmacokinetics of valacyclovir in subjects 1 month of age or older in order to assist in the design of a safer, more beneficial study of its pharmacokinetics in neonates under 2 weeks of age.",University of Alabama at Birmingham,"David Kimberlin, MD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20353&GroupID=SUMMARIES
11278,"GSK, Sanofi",Exploration of regional heterogeneity in trials assessing the efficacy of recent non-insulin glucose lowering drugs on cardiovascular outcomes,"Pharmacologie clinique, Université Grenoble Alpes Centre d'Investigation Clinique, Inserm CIC1406 CHU Grenoble Alpes Laboratoire HP2, Inserm UMR 1042 Tel: 06 73 98 36 37 mroustit@chu-grenoble.fr",ROUSTIT MATTHIEU,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20599&GroupID=SUMMARIES
11280,GSK,Antibody response to primary and booster immunization in infants born to mothers immunized with pertussis-containing vaccines during pregnancy versus unimmunized women: a systematic review and meta-analysis,"University of British Columbia, Canada",Dr. Manish Sadarangani,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20396&GroupID=SUMMARIES
11283,GSK,Association between Vaginal Infection and Cervical Non-HPV16/18 Infection in Women after Bivalent HPV Vaccination,"Cancer Hospital, Chinese Academy of Medical Sciences",Fanghui Zhao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20338&GroupID=SUMMARIES
11288,Novartis,Clinical Trial Diversity for Common Dermatologic Diseases: A Systematic Review,University of Pennsylvania,Junko Takeshita,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20847&GroupID=SUMMARIES
11298,GSK,Development of personalised predictive models for the evolution of atopic dermatitis severity in response to treatment,"Department of Bioengineering, Imperial College London",Reiko Tanaka,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20341&GroupID=SUMMARIES
11302,GSK,Assessment of the prognostic impact of including standard serological markers in the definitions of remission and low lupus disease activity in patients with SLE,"University of Crete Medical School; University Hospital of Heraklion, Greece",George Bertsias,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20352&GroupID=SUMMARIES
11340,GSK,Towards precision medicine in Chronic Obstructive Pulmonary Diseases: predicting individual treatment response and general outcomes in SUMMIT,"University Hospitals Leuven Department of Respiratory Diseases Research Laboratory BREATHE, Department CHROMETA, KU Leuven Herestraat 49 3000 Leuven Belgium",Wim Janssens,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20395&GroupID=SUMMARIES
11347,GSK,"Estimation of primary, secondary and composite effects of the RTSS/AS01 vaccine",London School of Hygiene&Tropical Medicine,Paul Milligan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20597&GroupID=SUMMARIES
11384,GSK,Human papillomavirus(HPV) vaccine efficacy and immunogenicity in women with existing HPV infections,"National Cancer Center & Cancer Hospital,Chinese Academy of Medical Sciences",Fanghui Zhao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20393&GroupID=SUMMARIES
11385,Novartis,Can changes in blood eosinophils (white blood cells) following treatment with inhaled corticosteroids predict clinical response in chronic obstructive pulmonary disease? A post-hoc analysis of the FLAME trial.,"Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester,  Manchester, UK.  and  North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. ","Prof. Jørgen Vestbo DMSc, FRCP, FERS, FMedSci.",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20873&GroupID=SUMMARIES
11402,GSK,Examination of Placebo Variance,University of Miami Department of Biochemistry and Molecular Biology Miller School of Medicine,Edward Bowen,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21096&GroupID=SUMMARIES
11435,GSK,Natural history of human papillomavirus and associated lesions in healthy Chinese women,"National Cancer Center & Cancer Hospital,Chinese Academy of Medical Sciences",Fanghui Zhao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20399&GroupID=SUMMARIES
11485,Novartis,Comorbidity and Clinical Trials of Disease-Modifying Therapies in Multiple Sclerosis,The University of Texas Southwestern Medical Center ,Amber Salter,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20934&GroupID=SUMMARIES
11487,GSK,A secondary Data-Analysis of Post-Traumatic Stress Disorder (PTSD) and Clinician-Administered PTSD Scale for DSM-5 (CAPS- 5),"Tunnell Government Services, Inc., Subcontractor to General Dynamics Information Technology (GDIT) working in support of US Army Medical Materiel Development Activity, Warfighter Brain Health (WBH) Project Management Office (PMO)","Elyse Katz, Ph.D. ",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20619&GroupID=SUMMARIES
11492,"Eisai, Novartis","Meta-analysis of efficacy of cholinesterase inhibitors on individual neuropsychiatric symptoms in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies.",UMCG,Iris Sommer,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20933&GroupID=SUMMARIES
11504,GSK,Translating randomized controlled trial data to an external target population: a secondary analysis of data from the RV1 trial in South Africa and Malawi,"University of North Carolina at Chapel Hill, Department of Epidemiology",Denise St. Jean,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20825&GroupID=SUMMARIES
11506,GSK,Review of the relation of parasite density and symptomatic disease in malaria infections,World Health Organization,Jane Cunningham,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21098&GroupID=SUMMARIES
11520,Sanofi,"Tripartite Estimands for Adherence Causal Inference in Clinical Trials, With Applications for the Development of COVID-19 Treatments","Statistics, Purdue University",Arman Sabbaghi,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20881&GroupID=SUMMARIES
11529,Sanofi,B cells and disease activity and anti-drug responses prior to and following alemtuzumab infusion for multiple sclerosis,Blizard Institute Barts and the London School of Medicine Queen Mary University of London,David Baker,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20824&GroupID=SUMMARIES
11560,GSK,Emotional blunting by mechanism of second-generation antidepressants: comparing bupropion and serotonin reuptake inhibitors,"University of Saskatchewan, Department of Psychiatry",Dr. Evyn Peters,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20823&GroupID=SUMMARIES
11593,Sanofi,Update of individual data meta-analysis of intra-articular corticosteroids in knee and hip osteoarthritis ,"Institute of Bone and Joint Research, University of Sydney Department of Rheumatology, Royal North Shore Hospital. Sydney, Australia",Dr Shirley Yu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20938&GroupID=SUMMARIES
11597,"Astellas, GSK, Novartis",Inferential reproducibility of therapeutic research: a registered report for a cross-sectional study of RCTs available on major data-sharing platforms,Psychiatrist at CHU Rennes and Professor at Université de Rennes 1,Florian Naudet,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21049&GroupID=SUMMARIES
11627,GSK,Validation of the diabetes Chronic Kidney Disease (CKD) and Heart Failure (HF) model in the HARMONY Outcomes trial,Tulane University School of Public Health and Tropical Medicine,Lizheng Shi,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20848&GroupID=SUMMARIES
11654,"GSK, Sanofi",An individual participant data meta-analysis to evaluate a new category of hypoglycemic drugs (GLP-1RAs) on type 2 diabetes mellitus patient sub-groups,"School of public health, Peking University",Feng Sun,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20872&GroupID=SUMMARIES
11673,GSK,Examination of new systemic lupus erythematosus (SLE) activity index development,"Department of Rheumatology, Kobe City Medical Center General Hospital",Shuji Sumitomo,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20931&GroupID=SUMMARIES
11683,"GSK, Novartis",A systematic review of the steroid sparing effect of biologicals in severe asthma,"EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Portugal & Faculdade de Medicina da Universidade do Porto, Portugal & Centro Hospitalar São João, Porto, Portugal",André Moreira,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20992&GroupID=SUMMARIES
11697,GSK,Modelling approaches for antibody decay of malaria vaccines,Laboratory of Clinical Immunology and Microbiology National Institute of Allergy and Infectious Disease National Institutes of Health,Jennifer Kwan,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20875&GroupID=SUMMARIES
11714,Novartis,The Difference Between Cystatin C- and Creatinine- Based Assessment of Renal Function in Heart Failure Patients: Insights From PARADIGM-HF and RELAX-AHF ,Columbia University Medical Center,Alberto Pinsino,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21125&GroupID=SUMMARIES
11730,Astellas,Promising subgroup identification method based on biomarkers for precision medicine.,"Biostatistics department of Public Health school, Harbin Medical University, China",Kang Li,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20935&GroupID=SUMMARIES
11731,GSK,Assessing the impact of season and schedule of vaccination on the immunogenicity of childhood vaccines,Max Planck Institute for Infection Biology,Sarah Kramer,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21014&GroupID=SUMMARIES
11772,ViiV,Determining an optimal pharmacokinetic target for dolutegravir ,"Pharmacometrics Laboratory, Division of Clinical Pharmacology, The University of Cape Town.",Aida N Kawuma,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20876&GroupID=SUMMARIES
11795,Novartis,The effects of systemic anti-infective concomitant medications on progression of neurological diseases,experimind ,Chaim Singal ,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20936&GroupID=SUMMARIES
11798,"Eisai, GSK, Novartis",What are the re-identification risk scores of publicly available anonymised clinical trial datasets? ,Edinburgh Clinical Trials Unit - The University of Edinburgh,Aryelly Rodriguez,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21082&GroupID=SUMMARIES
11801,Sanofi,Regulatory decision criteria on the suitability of the glycated hemoglobin level (HbA1c) as a surrogate for cardiac events. ,Hochschule Koblenz - RheinAhrCampus Fachbereich Mathematik und Technik,Malwina Mackowiak,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=20932&GroupID=SUMMARIES
11808,GSK,Evaluating the role of stochasticity in the clearance of HPV infections in young adults.,"MIVEGEC department, CNRS (Montpellier, France)",Samuel ALIZON,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21062&GroupID=SUMMARIES
11833,"GSK, Novartis","Development, Validation, and Implementation of an Individualized Risk Prediction Tool for Exacerbations in Severe Asthma",National University of Singapore,Wenjia Chen,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21061&GroupID=SUMMARIES
11874,GSK,Examine the efficacy and safety of Belimumab in treatment of newly diagnosed Systemic Lupus Erythematosus in Chinese population,Peking Uion Medical College Hospital,Xiaomei Leng ,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21015&GroupID=SUMMARIES
11879,GSK,Predicting individual treatment effects with machine learning in IMPACT,"University Hospitals Leuven Department of Respiratory Diseases Research Laboratory BREATHE, Department CHROMETA, KU Leuven Herestraat 49 3000 Leuven Belgium",Wim Janssens,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21052&GroupID=SUMMARIES
11915,GSK,Artificial Intelligence Algorithms for Analysis of Geographic Atrophy ,"Dept of Ophthalmology and Visual Sciences, University of Wisconsin, Madison.  ",Amitha Domalpally,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21016&GroupID=SUMMARIES
11927,GSK,EVALUATION OF THE EFFECTS OF CARDIOVASCULAR DRUGS ON SURVIVAL AND EXACERBATIONS IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ,University of Cambridge & Cambridge University Hospitals NHS Foundation Trust,Marie Fisk,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21144&GroupID=SUMMARIES
11950,"GSK, Novartis",Making real world predictions for clinical outcomes in Relapsing-Remitting Multiple Sclerosis,"Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland",Georgia Salanti,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21102&GroupID=SUMMARIES
11973,Novartis,Evaluation of acute changes in kidney function with serelaxin in acute heart failure,"Tufts Medical Center, Tufts University School of Medicine","Wendy McCallum, MD, MS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21050&GroupID=SUMMARIES
11995,GSK,Study to Evaluate Plasmodium vivax malaria pharmacometric Responses in blood and liver staGes to Eight AminoquinoliNe Treatments (SARGEANT),Mahidol Oxford Tropical Medicine Research Unit,Nicholas J White,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21051&GroupID=SUMMARIES
11996,GSK,A Hidden Markov Modelling Approach for Measuring Migraine Treatment Success,University of Illinois at Urbana-Champaign,Eric A. Wayman,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21081&GroupID=SUMMARIES
11998,GSK,Prediction of efficacy and tolerability of antidepressants and mood stabilizers,"Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany",Lasse Brandt,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21095&GroupID=SUMMARIES
12004,Novartis,Surgical Margin Distance in Head and Neck Squamous Cell Carcinoma,"Karmanos Cancer Institute, Wayne State Univeristy","John David Cramer, MD, FACS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21013&GroupID=SUMMARIES
12016,GSK,Do psychometrics matter? The effects of advanced psychometric analyses on depression randomised trial outcomes,Royal College of Surgeons in Ireland,Frank Doyle,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21076&GroupID=SUMMARIES
12023,GSK,A Machine Learning Approach Identifies Modulators of Albiglutide on Preventing Cardiovascular and Renal Outcomes in People with Type 2 Diabetes: A Revisit to the HARMONY trial,&#9; University of Florida College of Pharmacy,Hui Shao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21078&GroupID=SUMMARIES
12036,Novartis,Summarising the therapeutic and adverse effects of anticancer medicines according to race and sex: pooled analysis of clinical trials of contemporary treatments for solid tumours_Novartis_032022,Flinders University,Dr Ashley Hopkins,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21060&GroupID=SUMMARIES
12051,Novartis,Systemic pharmacological treatments for chronic plaque psoriasis: A Systematic Review and an Individual-Patient Data Network Meta-Analysis of Randomized Controlled Trials,University Paris Est Creteil (UPEC),Emilie Sbidian,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21080&GroupID=SUMMARIES
12088,Novartis,Using modern causal inference methods to enhance the generalisability of randomised controlled trial evidence by leveraging observational data: the case of Deferasirox® for managing iron overload in transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS) patients,"Centre for Health Economics, University of York, UK",Andrea Manca,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21099&GroupID=SUMMARIES
12095,GSK,Interpersonal sensitivity and response to selective serotonin reuptake inhibitors,"Department of Psychiatry, University of Saskatchewan","Dr. Evyn Peters, MD, FRCPC, MSc",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21083&GroupID=SUMMARIES
12126,Novartis,SPondyloarthritis: EARly Definition (ASAS-SPEAR): Analysis of Symptom Duration Thresholds Using Pooled Data from Randomized Controlled Trials,"Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. Department of Rheumatology, Zuyderland Medical Center, Heerlen, the Netherlands",Sofia Ramiro,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21077&GroupID=SUMMARIES
12132,"GSK, Novartis",The Incidence of Screen Failures Among African American Patients in Clinical Trials Due to Low White Blood Cell Counts,Stanford University,Matthew Baker,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21145&GroupID=SUMMARIES
12135,GSK,Examining alternative core symptom inclusion criteria in randomized placebo-controlled trials for acute major depression,"Department of Psychiatry, University of Saskatchewan","Dr. Evyn Peters, MD, FRCPC, MSc",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21097&GroupID=SUMMARIES
12149,GSK,Developing a quantitative base for more effective and individualized ropinirole dosing regimen,"Faculty of Pharmacy, Jagiellonian University Medical College in Poland",Sebastian Polak,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21079&GroupID=SUMMARIES
12167,Novartis,ICS-RECODE: Predictors of treatment REsponse to inhaled corticosteroids (ICS) in COPD: randomised COntrolled trials individual participant Data re-Evaluation.,"1. North West Lung Centre, Manchester University NHS Foundation Trust. 2. Division of Immunology, Immunity to Infection & Respiratory Medicine, The University of Manchester.",Alexander G Mathioudakis,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21131&GroupID=SUMMARIES
12178,GSK,Population Pharmacokinetic Study involving different formulations of Salbutamol,"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Plácido da Costa, 4200-450 Porto, Portugal CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Plácido da Costa, 4200-450 Porto, Portugal",Nuno Filipe de Sousa Vale,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21107&GroupID=SUMMARIES
12205,Novartis,Pretreatment Lymphocyte Count and Response to Concurrent Chemoradiation in Head and Neck Cancer,"Karmanos Cancer Institute, Wayne State University","John Cramer, MD, FACS",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21101&GroupID=SUMMARIES
12227,Novartis,What is the most clinically significant endpoint for CAR-T therapeutic approach to achieve effective results for lymphoma patients: should we consider CAR-T cell therapy as a drug or as a therapeutic pathway?,"ALMA MATER STUDIORUM - Università di Bologna, Department of Medical and Surgical Sciences",Lisa Argnani,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21105&GroupID=SUMMARIES
12243,Novartis,Validation of a Personalised Axial Spondyoarthritis Metrology Index Using Data from Clinical Trials.  ,"Care and Public Health Research Institute CAPHRI, Maastricht, the Netherlands",Dafne Capelusnik,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21163&GroupID=SUMMARIES
12254,Novartis,Analysis of spleen volume kinetics with outcomes in patients with myelofibrosis treated with JAK inhibitors,"Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA ","Raajit Rampal, MD, PhD",http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21198&GroupID=SUMMARIES
12282,Novartis,Selection of comparable subjects from different treatment groups when randomization is not feasible,"Business Transformation Solutions Global Business Solutions   Novartis Healthcare Pvt. Ltd. Salarpuria-Sattva Knowledge City Raidurg, Rangareddy District Madhapur / Hyderabad, Rangareddy 500008 ",SHYAM BIHARI TIWARI,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21130&GroupID=SUMMARIES
12305,"GSK, Novartis",Effectiveness of different treatments in Chronic obstructive pulmonary disease patients: an individual patient data pooled analysis of RCTs,"National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University",Zihui Wang,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21124&GroupID=SUMMARIES
12306,Novartis,"Mathematical modeling of patient-specific multiphasic dynamics of CAR-T cells, their interaction with healthy B cells, and the development of resistance.",National Laboratory for Scientific Computing in Brazil (LNCC),Regina Célia Cerqueira de Almeida,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21123&GroupID=SUMMARIES
12318,GSK,Persistent and isolated serum low C3 and lupus nephritis,Azienda Sanitaria Liguria 5- La Spezia (Italy),Lucio Manenti,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21129&GroupID=SUMMARIES
12369,Novartis,Machine learning-based identification of the target population for angiotensin-neprilysin inhibition given its heterogeneous treatment effect: a post-hoc analysis of the PARADIGM-HF and PARAGON-HF trials,Columbia University Irving Medical Center,Itsuki Osawa,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21138&GroupID=SUMMARIES
12377,Novartis,Improving heart failure with reduced ejection fraction (HFpEF) treatment using a mathematical model of physiology,University of Mississippi Medical Center,John S. Clemmer,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21142&GroupID=SUMMARIES
12388,GSK,High-risk human papillomavirus genotyping concordance between paired cervical exfoliated cells and biopsies,"National Cancer Center & Cancer Hospital,Chinese Academy of Medical Sciences",Fanghui Zhao,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21139&GroupID=SUMMARIES
12390,Novartis,Evaluating the impact of angiotensin receptor blocker use on the response to Icenticaftor. ,University of Kansas Medical Center Department of Internal Medicine,Matthias Salathe,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21162&GroupID=SUMMARIES
12410,Novartis,"Project 1: Comprehend common behavior patterns in different clinical trials, considering perspectives such as subject safety, study endpoints, and others. Project 2: Develop an algorithm(s) for the identification of &quot;Duplicated Subjects&quot;.",Cyntegrity Germany GmbH  ,Anastasia Shapovalova,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21143&GroupID=SUMMARIES
12414,GSK,Can a core set of disease activity domains define response in systemic lupus erythematosus clinical trials? An analysis of three Phase 3 randomised controlled trials of belimumab. ,Monash University School of Clinical Sciences ,Kathryn Connelly,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21161&GroupID=SUMMARIES
12427,GSK,A comparative study of anti-hypertensive drugs prediction models for the elderly based on machine learning algorithms,China Pharmaceutical University,Guo Yu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21141&GroupID=SUMMARIES
12428,Novartis,Association of Obesity and Incidence of Lung Cancer with Interleukin-1&#946; Antagonism,"Roswell Park Comprehensive Cancer center,  Jacobs School of Medicine and Biomedical Sciences, University at Buffalo Buffalo, New York, USA. 14201",SAI YENDAMURI,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21160&GroupID=SUMMARIES
12435,Novartis,Effectiveness and safety of janus kinase inhibitors in hospitalized patients with COVID-19: Systematic review and individual patient data meta-analysis of randomized trials,"1) CLEAR Methods Center, Division Clinical Epidemiology, Department Clinical Research, University Hospital Basel (Prof. M. Briel, MD PhD) 2) Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital and University of Oslo, Oslo, Norway (Dr. Inge Olsen, PhD) 3) Bristol Medical School, Medical Statistics, University of Bristol, UK (Prof. Jonathan Sterne, PhD). This project is supported and reviewed by Prof. M. Briel, he is my main mentor. ",Alain Amstutz MD PhD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21140&GroupID=SUMMARIES
12448,Novartis,PCSK9 and Heart Failure,University of Porto,Joao Pedro Ferreira MD PhD,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21200&GroupID=SUMMARIES
12456,Novartis,Systematic review and network meta-analysis of the efficacy and safety of systemic treatments in patients affected by chronic urticaria.,"1 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. 2 Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada.  3 Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. 4 The Research Institute of St. Joe's Hamilton, Hamilton, Ontario, Canada.",Derek Chu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21177&GroupID=SUMMARIES
12468,Novartis,Examining statistical methods that leverage the hierarchical structure of adverse events for signal detection in randomised controlled trials,"Pragmatic Clinical Trials Units, Queen Mary University of London",Laetitia de Abreu Nunes,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21216&GroupID=SUMMARIES
12480,"Astellas, GSK, Novartis",An empirical study of tumor markers in clinical routine: Applying different functional forms to continuous variable data,Institute of Clinical Biometrics Center for Medical Data Science Medical University of Vienna,Georg Heinze,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21199&GroupID=SUMMARIES
12489,Novartis,Exploring Sex-related Mechanisms of Psoriatic Arthritis response to advanced therapies (EXSEMP): Individual participant data (IPD) meta-analysis of randomized controlled trials of advanced therapies,"Women's College Hospital, University of Toronto  ",Lihi Eder,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21189&GroupID=SUMMARIES
12500,Novartis,Efficacy of Glucose-Lowering Drugs for Young-Onset Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized Control Trials,"Toronto General Hospital, University Health Network   Director, Epidemiologic and Applied Research Lab in Young-Onset Diabetes (EARLY Diabetes)  Assistant Professor, Department of Medicine, University of Toronto ",Dr. Calvin Ke ,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21197&GroupID=SUMMARIES
12525,Novartis,Evaluating the Impact of Comorbidities on the Efficacy of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure Patients with Preserved Ejection Fraction,"Department of Cardiology, Yongin Severance Hospital, Yonsei University College of Medicine, South Korea",SungA Bae,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21164&GroupID=SUMMARIES
12566,Novartis,Examining Heterogeneity in Response to Disease-Modifying Therapy in Multiple Sclerosis,UT Southwestern Medical Center,Amber Salter,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21201&GroupID=SUMMARIES
12569,Novartis,Efficacy and safety of monoclonal antibodies in patients with uncontrolled asthma: a systematic review and network meta-analysis.,McMaster University ,Dr. Derek Chu,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21215&GroupID=SUMMARIES
12612,Novartis,Development of an Automated Clinical Data Management and Analysis Platform for Streamlined Reporting and Regulatory Compliance,"K3-Innovations, Inc",Anil Mogha,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21202&GroupID=SUMMARIES
12697,Novartis,Validity and consistency of matching-adjusted indirect comparison (MAIC),"Delta Hat Limited, Nottingham, UK & Department of Statistics, University College London, London, UK",Anthony Hatswell,http://www.clinicalstudydatarequest.com/Posting.aspx?ID=21217&GroupID=SUMMARIES
